Sandbox:DN

Revision as of 20:32, 13 January 2017 by Dima Nimri (talk | contribs)
Jump to navigation Jump to search
Disease Can Present With Cardiac Enzymes Catecholamine Levels ECG Findings Echocardiography Findings
Stress Cardiomyopathy Chest pain, dyspnea Transiently elevated ST elevation in precordial leads LV regional dysfunction
Pheochromocytoma Chest pain, dyspnea Can be positive Persistently elevated ST elevation in precordial leads LV regional dysfunction
Anterior MI Chest pain, dyspnea ↑↑↑ N/A ST elevation in precordial leads Dysfunction at area of infarction
Myocarditis Chest pain, dyspnea, fever May be acutely elevated N/A May show atrial fibrillation, LBBB or AV block Diffuse hypokinesia
Dilated Cardiomyopathy Dyspnea, dyspnea on exertion, cough, edema, fatigue Usually negative N/A May show atrial fibrillation, LBBB or AV block LV enlargement
Hypertrophic Cardiomyopathy Chest pain, dyspnea, syncope, sudden cardiac death Usually negative N/A Common findings include: LV hypertrophy, systolic anterior motion of the mitral valve, asymmetric septal hypertrophy
Stress Cardiomyopathy Anterior Wall MI
Chest pain and dyspnea as presenting symptoms
ST elevation in precordial leads
Peak CK-MB value <50 U/L ↑↑↑
6-month outcome Favorable outcome Higher rates of:
  • Death
  • Cardiac death
  • Reinfarction
  • Rehospitalization
  • Major cardiac events

Stress cardiomyopathy must also be differentiated from Takotsubo-like syndrome caused by medical conditions, such as pheochromocytoma:[1]

Stress Cardiomyopathy Takotsobu-like Syndrome
Chest pain mimicking MI
EKG findings (ST elevation)
Positive cardiac enzymes
LV regional dysfunction
Patient profile Post-menopausal women Younger patients with less female predominance
Catecholamine levels Transient elevation Constantly elevated
Complications Higher rate of complications, including:
  1. Mikail N, Hess S, Jesel L, El Ghannudi S, El Husseini Z, Trinh A, Ohlmann P, Morel O, Imperiale A (2013). "Takotsubo and Takotsubo-like syndrome: a common neurogenic myocardial stunning pathway?". Int. J. Cardiol. 166 (1): 248–50. doi:10.1016/j.ijcard.2012.09.116. PMID 23058349.